Alector Inc Sustainability Reports
Alector, Inc. is a clinical-stage biotechnology company that develops therapies for neurodegenerative diseases. The company advances a pipeline of product candidates that target immune system dysfunctions to treat conditions such as Alzheimer's disease and frontotemporal dementia.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300Z8RQOIY1JMHC25
FIGI: BBG00N0PL214
3 reports from 2020 to 2024
